Intellectual Property Attorneys

Photo

Hultquist IP Pharmaceutical Patents print this page

  • U.S. Patent 9,802,929
  • 10/31/17
  • Benzo Five-Membered Nitrogen Heterocyclic Piperidine Or Piperazine Derivatives And Preparation Methods And Pharmaceutical Compositions Thereof
  • U.S. Patent 9,630,962
  • 4/25/17
  • 4-Amino-6-(2,6-Dichlorophenyl)-2-(Phenylamino)-Pyrido[2,3-d]Pyrimidin-7(8H)-One Derivatives, Synthesis And Uses Thereof
  • U.S. Patent 9,155,748
  • 10/13/15
  • Aromatic Carboxylic Acid Derivatives For Treatment And Prophylaxis Of Gastrointestinal Diseases Including Colon Cancers
  • U.S. Patent 9,150,582
  • 10/6/15
  • Composition And Method For Neuropeptide S Receptor (NPSR) Antagonists
  • U.S. Patent 9,150,581
  • 10/6/15
  • Nicotinic Receptor Compounds
  • U.S. Patent 9,056,117
  • 6/16/15
  • Herbal Formulation For Wound Healing
  • U.S. Patent 9,056,126
  • 6/16/15
  • Hydrogel Formulations
  • U.S. Patent 9,040,580
  • 5/26/15
  • Method For The Prevention Or Treatment Of Degenerative Neurological Brain Disorders
  • U.S. Patent 8,865,934
  • 10/21/14
  • Method for Preparing Ramalin
  • U.S. Patent 8,822,531
  • 9/2/14
  • Honokiol Analogs And Their Use In Treating Cancers
  • U.S. Patent 8,815,829
  • 8/26/14
  • 3'-Azido Purine Nucleotide Prodrugs For Treatment Of Viral Infections
  • U.S. Patent 8,815,835
  • 8/26/14
  • 9-Aminonoscapine And Its Use In Treating Cancers, Including Drug-Resistant Cancers
  • U.S. Patent 8,729,014
  • 5/20/14
  • Novel Specific HCV NS3 Protease Inhibitors
  • U.S. Patent 8,691,851
  • 4/8/14
  • Lanthanide Metal Complexes Useful In Treating Cancer
  • U.S. Patent 8,686,042
  • 4/1/14
  • GSK-3 Inhibitors
  • U.S. Patent 8,663,684
  • 3/4/14
  • Lactose And Cellulose-Based Tableting Aid
  • U.S. Patent 8,664,233
  • 3/4/14
  • Substituted 5H-Pyrimido[5,4-B]Indoles, Method For The Production Thereof And Use Thereof For Treating Non-Solid Malignant Tumors Of The Blood-Producing System
  • U.S. Patent 8,628,801
  • 1/14/14
  • Pegylated Nanoparticles
  • U.S. Patent 8,609,627
  • 12/17/13
  • Purine Nucleoside Monophosphate Prodrugs For Treatment Of Cancer And Viral Infections
  • U.S. Patent 8,586,627
  • 11/19/13
  • Honokiol Analogs And Their Use In Treating Cancers
  • U.S. Patent 8,580,853
  • 11/12/13
  • Analgesic Composition and Method of Making Same
  • U.S. Patent 8,569,466
  • 10/29/13
  • Aromatic Carboxylic Acid Derivatives for Treatment and Prophylaxis of Gastrointestinal Diseases Including Colon Cancers
  • U.S. Patent 8,492,411
  • 7/23/13
  • 5-(4-methanesulfonyl-phenyl)-thiazole Derivatives for the Treatment of Acute and Chronic Inflammatory Diseases
  • U.S. Patent 8,481,500
  • 7/9/13
  • Compounds having neuroprotective properties
  • U.S. Patent 8,444,960
  • 5/21/13
  • Topical Administration Carrier Composition and Therapeutic Formulations Comprising Same
  • U.S. Patent 8,431,167
  • 4/30/13
  • Plant Extracts Composition for the Treatment of Liver Dysfunction-Jaundice
  • U.S. Patent 8,415,321
  • 4/9/13
  • Nucleoside Derivatives For Treatment Of Caliciviridae Infections, Including Norovirus Infections
  • U.S. Patent 8,394,957
  • 3/12/13
  • 9-Aminonoscapine and its Use in Treating Cancers, Including Drug-Resistant Cancers
  • U.S. Patent 8,388,984
  • 3/05/13
  • Site Specific Intestinal Delivery of Adsorbents, Alone or in Combination with Degrading Molecules.
  • U.S. Patent 8,389,525
  • 3/05/13
  • Small Molecules for Inhibition of Protein Kinases
  • U.S. Patent 8,377,888
  • 2/19/13
  • Method of Predicting Clinical Response to Cisplatin or Carboplatin Chemotherapeutic Treatment
  • U.S. Patent 8,246,946
  • 8/21/12
  • Treatment of bipolar disorder utilizing anti-fungal compositions
  • U.S. Patent 8,192,733
  • 6/5/2012
  • Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
  • U.S. Patent 8,178,501
  • 5/15/2012
  • Antibiotic Combinations for Providing Total Solution to the Treatment of Infections
  • U.S. Patent 8,147,815
  • 4/3/2012
  • Topical Administration Carrier Composition and Therapeutic Formulations Comprising Same
  • U.S. Patent 8,119,111
  • 2/21/2012
  • Topical Administration Carrier Composition and Therapeutic Formulations Comprising Same
  • U.S. Patent 8,106,000
  • 1/31/2012
  • Colonic Delivery of Adsorbents
  • U.S. Patent 8,097,607
  • 1/17/2012
  • Low Dose Rifalazil Compositions
  • U.S. Patent 8,048,413
  • 11/1/2011
  • Site-Specific Intestinal Delivery of Adsorbents, Alone or in Combination with Degrading Molecules
  • U.S. Patent 7,968,085
  • 6/28/2011
  • Hydrogel Formulations
  • U.S. Patent 7,960,337
  • 6/14/2011
  • Parenteral Combination Therapy for Infective Conditions with Drug Resistant Bacterium
  • U.S. Patent 7,875,750
  • 1/25/2011
  • Method of Obtaining 2-Amino-6-Alkyl-Amino-4,5,6,7-Tetrahydrobenzothiazoles
  • U.S. Patent 7,842,821
  • 11/30/2010
  • Method of Obtaining Derivatives of 4-(N-Alkylamino)-5,6-Dihydro-4H-Thieno-[2,3-B]-Thiopyran
  • U.S. Patent 7,833,765
  • 11/16/2010
  • Galenic Formulation for Colon-Targeted Delivery of Active Ingredients
  • U.S. Patent 7,820,652
  • 10/26/2010
  • Regimen for the Administration of Rifamycin-Class Antibiotics
  • U.S. Patent 7,781,594
  • 8/24/2010
  • 5-(4 Methanesulfonyl-Phenyl)-Thiazole Derivatives for the Treatment of Acute and Chronic Inflammatory Diseases
  • U.S. Patent 7,671,208
  • 3/2/2010
  • Acetone Solvate of Phthaloyl Amlodipine
  • U.S. Patent 7,638,542
  • 12/29/2009
  • Method of Obtaining 2-amino-6-alkyl-amino-4,5,6,7-tetrahydro-benzothiazoles
  • U.S. Patent 7,582,307
  • 9/1/2009
  • Dermatological Composition
  • U.S. Patent 7,560,550
  • 7/14/2009
  • Method for the Production of OH Protected[4-(2.6-Diamino-9H-Purine-9-YL)-1.3-Dioxolane-2-YL]Methanol Derivatives
  • U.S. Patent 7,547,692
  • 6/16/2009
  • Rifamycin Analogs and Their Uses Thereof
  • U.S. Patent 7,109,349
  • 9/19/2006
  • Process for Obtaining Cizolirtine and its Enantiomers
  • U.S. Patent 6,924,288
  • 8/2/2005
  • Enantiomerically Pure Opioid Diarylmethylpiperzine and Methods of Using Same
  • U.S. Patent 6,376,224
  • 4/23/2002
  • Pharmaceutical Compositions for Eliminating Membrane-Mediated Cell Resistance
  • U.S. Patent 6,376,197
  • 4/23/2002
  • Diagnosis of Interstitial Cystitis
  • U.S. Patent 5,985,880
  • 11/16/1999
  • Compositions and Methods for Reducing Respiratory Depression and Attendant Side Effects in Mu Opioid Compounds
  • U.S. Patent 5,854,249
  • 12/29/1998
  • Method of Combating Physiological Conditions and Disease States with Opioid Diarylmethylpiperazines and Piperidines
  • U.S. Patent 5,807,858
  • 9/15/1998
  • Compositions and Methods for Reducing Respiratory Depression
  • U.S. Patent 5,723,453
  • 3/3/1998
  • Stabilized, Water-Soluble Aspirin Composition
  • U.S. Patent 5,681,830
  • 10/28/1997
  • Opioid Compounds
  • U.S. Patent 5,658,908
  • 8/19/1997
  • Opioid Diarylmethylpiperazines and Piperidines
  • U.S. Patent 5,574,159
  • 11/12/1996
  • Opioid Compounds and Methods for Making Therefor
  • U.S. Patent 5,552,404
  • 9/3/1996
  • Opioid Compounds and Methods for Using Same
  • U.S. Patent 5,434,143
  • 7/18/1995
  • Pharmaceutical Compositions Comprising Phosphite-Borane Compounds
  • U.S. Patent 5,399,732
  • 3/21/1995
  • Phosphite-Borane Compounds and Method of Making and Using the Same
  • U.S. Patent 5,312,816
  • 5/17/1994
  • Method of Combating Osteoporosis in Mammalian Subjects, Utilizing Organic Boron Compounds
  • U.S. Patent 5,256,394
  • 10/26/1993
  • Iodinated Cyclophosphazene Compounds
  • U.S. Patent 5,254,706
  • 10/19/1993
  • Process of Making Phosphite-Borane Compounds
  • U.S. Patent 5,143,907
  • 9/1/1992
  • Phosphite-Borane Compounds, and Method of Making and Using the Same